In 2024, the average length of stay (LOS) for dorsalgia cases varied widely across countries. While Germany had the highest LOS at 11.6 days, New Zealand and Sweden had the shortest at 3.5 days. Year-on-year trends from 2023 indicate diverse changes: Germany and Croatia showed no variation, whereas New Zealand saw a significant reduction of nearly 8%. Countries like Spain and Sweden also observed notable declines, reflecting an overall trend towards shorter hospital stays in some regions.
Looking ahead, it's crucial to monitor how advancements in medical technologies and outpatient care might further influence hospital LOS for dorsalgia cases. Countries with higher LOS may adopt practices from those with shorter stays, potentially leading to a more streamlined global approach. Additionally, variations in healthcare policies and treatment methods could significantly impact average LOS figures in the coming years.
Top countries in Hospital Average Length of Stay for Dorsalgia Cases by Country
| # | 10 Countries | Days | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 11.6 | 2023 | 0% | 0% | View data |
| 2 | 2 South Korea | 10.9 | 2023 | 0% | -0.18% | View data |
| 3 | 3 Austria | 10.3 | 2023 | +0.98% | +0.39% | View data |
| 4 | 4 Croatia | 10.3 | 2023 | +0.98% | View data | |
| 5 | 5 Italy | 6.2 | 2023 | 0% | -1.83% | View data |
| 6 | 6 Spain | 5.3 | 2023 | -3.64% | -3.09% | View data |
| 7 | 7 Mexico | 4.8 | 2023 | +2.13% | +1.76% | View data |
| 8 | 8 Israel | 4.5 | 2023 | 0% | +0.91% | View data |
| 9 | 9 New Zealand | 3.5 | 2023 | -18.6% | -7.96% | View data |
| 10 | 10 Sweden | 3.5 | 2023 | 0% | -4.03% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
